Does High PCT Warrant Longer Therapy? - Summary - MDSpire

Does High PCT Warrant Longer Therapy?

  • By

  • Andrea Surnit

  • July 15, 2026

  • 4 min

Share

Objective:

To analyze the relationship between elevated procalcitonin (PCT) levels and the duration of antibiotic therapy in patients with bloodstream infections.

Approach:
  • Study Design: A planned cohort analysis within the BALANCE trial, comparing 7 vs 14 days of antibiotic therapy among hospitalized patients.
  • Patient Population: Included 125 patients from 12 Canadian centers, with serum collected on day 7 of treatment.
  • PCT Measurement: PCT levels were quantified using an antibody-based assay, with results not disclosed to clinicians during the trial.
Key Findings:
  • 90-day mortality was 22% in patients with high PCT levels (≥250 pg/mL) compared to 6% in those with lower levels.
  • Patients in the high-PCT group had higher baseline Sequential Organ Failure Assessment scores and were more likely to have diabetes, dialysis dependency, and community-onset bloodstream infections.
  • No significant differences in ICU mortality, ICU-free days, hospital-free days, or adherence to treatment duration between high and low-PCT groups.
  • Randomization to longer antibiotic courses did not improve 90-day mortality or secondary outcomes.
  • In a sensitivity analysis defining high PCT as greater than 500 pg/mL, no difference in 90-day mortality was observed between treatment-duration groups.
Interpretation:

Elevated PCT levels may not be a reliable indicator for extending antibiotic therapy duration, as they could be influenced by host factors such as immune dysregulation and comorbidities.

Limitations:
  • Small sample size of 125 patients limits statistical power.
  • Findings may not be generalizable to the broader BALANCE population or other countries.
  • PCT was measured only once, limiting the assessment of changes over time.
  • Exclusion of bloodstream infections caused by Staphylococcus aureus and Staphylococcus lugdunensis affects generalizability.
Conclusion:

A fixed 7-day course of antibiotics appears sufficient for most patients, and PCT measurement is not necessary for discontinuing therapy at 7 days for the majority of patients.

Sources:

Original Source(s)

Related Content